Teal Health
At-home cervical cancer screening and HPV testing
CORE INFO
Teal Health sells an FDA-authorized at-home sample-collection device paired with a virtual clinical visit, lab HPV testing, online results, and follow-up coordination. The service is designed for eligible patients and distributed through consumers, employers, health plans, providers, and health systems to increase cervical-cancer screening.
- Series A: $22 million led by .406 Ventures, announced September 22, 2026, with participation from Emerson Collective, Forerunner, Serena Ventures, and MPower Partners.mobihealthnews.com
- Early-patient profile: more than 50% had been overdue for cervical-cancer screening by at least five years, and approximately 20% had never been screened.jpmorgan.com
- The Associated Press covered Teal's FDA authorization for an at-home cervical-cancer screening kit, including its prescription, laboratory-testing, and follow-up requirements.apnews.com
WHY WE WOULD WORK AT TEAL HEALTH
Expand Screening Access
Help advance Teal Health's mission to get all women and people with a cervix screened for cervical cancer. The Teal Wand™ removes the speculum barrier through convenient, privacy-centered at-home HPV screening.
Scale a Proven Breakthrough
Join a company moving from FDA authorization and clinical validation into nationwide commercialization. Teal launched in all 50 states in January 2026 and recently raised a $22 million Series A to broaden access.
Build Clinical-Grade Innovation
Work at the intersection of medical devices, telehealth, diagnostics, and preventive care. Teal combines an FDA-authorized collection device with Roche cobas® HPV testing, virtual clinical visits, and provider-coordinated follow-up.
Reach Underserved Patients
Teal's early patients included people who had gone five or more years without screening and others who had never been screened. Partnerships with UC Davis Health, WashU Medicine, employers, health plans, and providers extend that impact beyond direct-to-consumer care.
Design Around Real People
Help shape products built around comfort, privacy, body diversity, and ease of use. In the SELF-CERV trial, 94% of participants preferred the Teal Wand to in-clinic screening and 98% collected a valid sample.
Grow With a Mission-Driven Team
Join a focused team of roughly 39 people as Teal expands its device, care platform, and partner infrastructure. Its culture emphasizes exceptional work, elevating women, and learning every day—while recognized milestones include TIME's Best Invention and Fast Company's Next Big Thing in Tech.
MARKET AND TRACTION
GROWTH TACTICS
✦ KEY METRICNOTABLE CUSTOMERS
KEY METRICS
✦ KEY METRICCOMPETITIVE ADVANTAGE
MARKET POSITION
✦ KEY METRICPRODUCT AND TECH
Teal Wand Screening
The FDA-authorized Teal Wand™ enables eligible patients to collect vaginal samples at home without a speculum for primary HPV testing. Its body-inclusive, user-centered design helps reduce discomfort and barriers to cervical-cancer screening.
Virtual Clinical Care
Teal's telehealth service includes an eligibility review with an OB-GYN or nurse practitioner and guidance through the at-home screening process. Affiliated physician-owned practices and clinicians provide the clinical care.
HPV Laboratory Testing
Collected samples are sent for primary HPV testing using the Roche cobas® HPV test, the same test used for clinical screening. This connects at-home sample collection with established laboratory diagnostics.
Digital Screening Platform
Teal's end-to-end platform supports ordering, kit fulfillment, return logistics, secure online results, and screening-adherence workflows. It also provides partner-facing infrastructure for providers, health systems, health plans, and employers.
Follow-Up Navigation
Providers review results and coordinate referrals or follow-up care when HPV results are abnormal. This helps connect screening outcomes to the patient's care team rather than treating the service as a standalone test.